Shannon Weiman
Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.
Scholarship Opportunities & Abstract Deadlines for 2022 Keystone Symposia Conferences
It's that time of year again! As we prepare to delve into yet another exciting season of biomedical breakthroughs and innovation with the launch of the Keystone Symposia 2022 season, now is the...
Keypoint Newsletter: Partnering with the Bill & Melinda Gates Foundation to Expand Global Access...
By Graycen Wheeler and Shannon Weiman Keystone Symposia strives to facilitate connections among scientists from all backgrounds in order to promote stimulating discussions and spur innovative collaborations. But attending scientific conferences is a notoriously cost-prohibitive...
Keypoint Newsletter: Envisioning the Future of Hybrid Meetings– Adapting to the New Normal
By Thale Jarvis The enforced hiatus from travel during the pandemic provided a valuable learning opportunity, prompting the life science community to share science in new and innovative ways; our 2020-21 eSymposia series facilitated extensive...
Keypoint Newsletter: Spotlight on Innovation with Dr. Francisco Quintana
By Shannon Weiman Here at Keystone Symposia we are accustomed to hosting luminaries and Nobel Prize winners, but every once in a while a new face comes along that really knocks our socks off. This...
Keypoint Newsletter: Keystone Symposia in the News
Keystone Symposia made waves in the media this year, leading the field in developing a virtual meeting format designed to not only convey the latest scientific breakthroughs, but equally important, to engage audiences from...